Jenny Högström

5PUBLICATIONS
57CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 30, 2026
A noncanonical function of the tyrosine degradation enzyme FAH drives CDK4/6 inhibitor resistance in breast cancer.

|Oct 02, 2025
Dual membrane receptor degradation via folate receptor targeting chimera.

Zhen Wang, Zhixin Li, Jenny Högström

|Jan 22, 2025
A Multipotent PROX1+ Tumor Stem/Progenitor Cell Population Emerges during Intestinal Tumorigenesis and Mediates Radioresistance in Colorectal Cancer.

Pauliina Kallio, Cinzia Bessone, Fatemeh Seyednasrollah

|Jul 18, 2024
Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer.

Alissandra L Hillis, Timothy D Martin, Haley E Manchester

|Nov 17, 2021
Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas.

Sarika Heino, Shentong Fang, Marianne Lähde

Pageof 1

Frequent Collaborators

3 joint publications

Taru Muranen

2 joint publications

Tatiana V Petrova

2 joint publications

Nina Kozlova

2 joint publications

Kari Alitalo